These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1648 related items for PubMed ID: 32683540

  • 21. Combination of circulating tumor cells and 18F-FDG PET/CT for precision diagnosis in patients with non-small cell lung cancer.
    Sun M, Lu D, Li X, Wang J, Zhang L, Yang P, Yang Y, Shen J.
    Cancer Med; 2024 Sep; 13(18):e70216. PubMed ID: 39302034
    [Abstract] [Full Text] [Related]

  • 22. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
    Nakajima N, Kataoka M, Sugawara Y, Ochi T, Kiyoto S, Ohsumi S, Mochizuki T.
    Int J Radiat Oncol Biol Phys; 2013 Nov 15; 87(4):738-46. PubMed ID: 24064322
    [Abstract] [Full Text] [Related]

  • 23. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, Lee JD.
    J Nucl Med; 2014 Jun 15; 55(6):898-904. PubMed ID: 24711649
    [Abstract] [Full Text] [Related]

  • 24. Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
    Yoo J, Kim BS, Chung J, Yoon HJ.
    Medicine (Baltimore); 2017 Aug 15; 96(31):e7657. PubMed ID: 28767583
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.
    Son SH, Kim DH, Hong CM, Kim CY, Jeong SY, Lee SW, Lee J, Ahn BC.
    BMC Cancer; 2014 Aug 12; 14():585. PubMed ID: 25112709
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
    Song BI, Lee SW, Jeong SY, Chae YS, Lee WK, Ahn BC, Lee J.
    J Nucl Med; 2012 Sep 12; 53(9):1337-44. PubMed ID: 22870824
    [Abstract] [Full Text] [Related]

  • 30. Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Rudžianskas V, Korobeinikova E, Rudžianskienė M, Jaselskė E, Adlienė D, Šedienė S, Kulakienė I, Padervinskis E, Jurkienė N, Juozaitytė E.
    Medicina (Kaunas); 2018 Dec 10; 54(6):. PubMed ID: 30544718
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
    Ahn SG, Park JT, Lee HM, Lee HW, Jeon TJ, Han K, Lee SA, Dong SM, Ryu YH, Son EJ, Jeong J.
    Breast Cancer Res; 2014 Dec 10; 16(6):502. PubMed ID: 25551703
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Eur J Nucl Med Mol Imaging; 2015 Aug 10; 42(9):1353-61. PubMed ID: 26067088
    [Abstract] [Full Text] [Related]

  • 36. Metabolic parameters of [18F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer.
    Markus M, Sartor H, Bjurberg M, Trägårdh E.
    Acta Oncol; 2023 Feb 10; 62(2):180-188. PubMed ID: 36815676
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.
    Higuchi T, Fujimoto Y, Ozawa H, Bun A, Fukui R, Miyagawa Y, Imamura M, Kitajima K, Yamakado K, Miyoshi Y.
    Ann Surg Oncol; 2019 Jul 10; 26(7):2175-2183. PubMed ID: 30941655
    [Abstract] [Full Text] [Related]

  • 39. Prognostic value of 18F-FDG PET/CT prior to breast cancer treatment. Comparison with magnetic resonance spectroscopy and diffusion weighted imaging.
    Kitajima K, Yamano T, Miyoshi Y, Katsuura T, Enoki T, Yamakado K.
    Hell J Nucl Med; 2019 Jul 10; 22(1):25-35. PubMed ID: 30843007
    [Abstract] [Full Text] [Related]

  • 40. Correlation between semiquantitative and volumetric 18F-FDG PET/computed tomography parameters and Ki-67 expression in breast cancer.
    Mohamadien NRA, Sayed MHM.
    Nucl Med Commun; 2021 Jun 01; 42(6):656-664. PubMed ID: 33560720
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 83.